Regulates the expression of VEGFR2, ZO‐1, occluding, and Claudin5 in ECs by targeting KLF2 and KLF4, consequently promoting vascular permeability and angiogenesis and enhancing CRC metastasis in lung PMN formation. Here, KLF4 is linked to colorectal carcinoma.